The innervation of taste buds is an excellent model system for studying the guidance of axons during targeting because of their discrete nature and the high fidelity of innervation. The pregustatory epithelium of fungiform papillae is known to secrete diffusible axon guidance cues such as BDNF and Sema3A that attract and repel, respectively, geniculate ganglion axons during targeting, but diffusible factors alone are unlikely to explain how taste axon terminals are restricted to their territories within the taste bud. Nondiffusible cell surface proteins such as Ephs and ephrins can act as receptors and/or ligands for one another and are known to control axon terminal positioning in several parts of the nervous system, but they have not been studied in the gustatory system. We report that ephrin-B2 linked β-galactosidase staining and immunostaining was present along the dorsal epithelium of the mouse tongue as early as embryonic day 15.5 (E15.5), but was not detected at E14.5, when axons first enter the epithelium. Ephrin-B1 immunolabeling was barely detected in the epithelium and found at a somewhat higher concentration in the mesenchyme subjacent to the epithelium. EphB1 and EphB2 were detected in lingual sensory afferents in vivo and geniculate neurites in vitro. Ephrin-B1 and ephrin-B2 were similarly effective in repelling or suppressing outgrowth by geniculate neurites in vitro. These in vitro effects were independent of the neurotrophin used to promote outgrowth, but were reduced by elevated levels of laminin. In vivo, mice null for EphB1 and EphB2 exhibited decreased gustatory innervation of fungiform papillae. These data provide evidence that ephrin-B forward signaling is necessary for normal gustatory innervation of the mammalian tongue.

Keywords:
Ephrin-B2, Laminin, Neurotrophin, Epithelium, Taste, Axon guidance
1.
Vilbig R, Cosmano J, Giger R, Rochlin MW: Distinct roles for Sema3A, Sema3F, and an unidentified trophic factor in controlling the advance of geniculate axons to gustatory lingual epithelium. J Neurocytol 2004;33:591-606.
2.
Dillon TE, Saldanha J, Giger R, Verhaagen J, Rochlin MW: Sema3A regulates the timing of target contact by cranial sensory axons. J Comp Neurol 2004;470:13-24.
3.
Huang T, Krimm RF: BDNF and NT4 play interchangeable roles in gustatory development. Dev Biol 2014;386:308-320.
4.
Huang T, Krimm RF: Developmental expression of Bdnf, Ntf4/5, and Trk B in the mouse peripheral taste system. Dev Dyn 2010;239:2637-2646.
5.
Lopez GF, Krimm RF: Epithelial overexpression of BDNF and NT4 produces distinct gustatory axon morphologies that disrupt initial targeting. Dev Biol 2006;292:457-468.
6.
Krimm RF, Miller KK, Kitzman PH, Davis BM, Albers KM: Epithelial overexpression of BDNF or NT4 disrupts targeting of taste neurons that innervate the anterior tongue. Dev Biol 2001;232:508-521.
7.
Nosrat IV, Lindskog S, Seiger A, Nosrat CA: Lingual BDNF and NT-3 mRNA expression patterns and their relation to innervation in the human tongue: similarities and differences compared with rodents. J Comp Neurol 2000;417:133-152.
8.
Mistretta CM, Goosens KA, Farinas I, Reichardt LF: Alterations in size, number, and morphology of gustatory papillae and taste buds in BDNF null mutant mice demonstrate neural dependence of developing taste organs. J Comp Neurol 1999;409:13-24.
9.
Oakley B, Brandemihl A, Cooper D, Lau D, Lawton A, Zhang C: The morphogenesis of mouse vallate gustatory epithelium and taste buds requires BDNF-dependent taste neurons. Brain Res Dev Brain Res 1998;105:85-96.
10.
Nosrat CA, Blomlof J, ElShamy WM, Ernfors P, Olson L: Lingual deficits in BDNF and NT3 mutant mice leading to gustatory and somatosensory disturbances, respectively. Development 1997;124:1333-1342.
11.
Runge EM, Hoshino N, Biehl MJ, Ton S, Rochlin MW: Neurotrophin-4 is more potent than brain-derived neurotrophic factor in promoting, attracting and suppressing geniculate ganglion neurite outgrowth. Dev Neurosci 2012;34:389-401.
12.
Hoshino N, Vatterott P, Egwiekhor A, Rochlin MW: Brain-derived neurotrophic factor attracts geniculate ganglion neurites during embryonic targeting. Dev Neurosci 2010;32:184-196.
13.
Rosebush MS, Rao SK, Samant S, Gu W, Handorf CR, Pfeffer LM, et al: Oral cancer: enduring characteristics and emerging trends. J Mich Dent Assoc 2012;94:64-68.
14.
Ringstedt T, Ibanez CF, Nosrat CA: Role of brain-derived neurotrophic factor in target invasion in the gustatory system. J Neurosci 1999;19:3507-3518.
15.
Nosrat CA, Olson L: Brain-derived neurotrophic factor mRNA is expressed in the developing taste bud-bearing tongue papillae of rat. J Comp Neurol 1995;360:698-704.
16.
Triantafyllou A, Coulter P: Structural organization of subgemmal neurogenous plaques in foliate papillae of tongue. Hum Pathol 2004;35:991-999.
17.
Mbiene JP, MacCallum DK, Mistretta CM: Organ cultures of embryonic rat tongue support tongue and gustatory papilla morphogenesis in vitro without intact sensory ganglia. J Comp Neurol 1997;377:324-340.
18.
Mistretta CM, Haus LF: Temporal and spatial patterns of tenascin and laminin immunoreactivity suggest roles for extracellular matrix in development of gustatory papillae and taste buds. J Comp Neurol 1996;364:535-555.
19.
Line SR, Fortes L, Graner E, Almeida OP: Immunochemical characterization and distribution of laminin in the rat tongue. Acta Histochem 1995;97:307-312.
20.
Xu NJ, Henkemeyer M: Ephrin reverse signaling in axon guidance and synaptogenesis. Semin Cell Dev Biol 2012;23:58-64.
21.
Flanagan JG, Vanderhaeghen P: The ephrins and Eph receptors in neural development. Annu Rev Neurosci 1998;21:309-345.
22.
Reber M, Hindges R, Lemke G: Eph receptors and ephrin ligands in axon guidance. Adv Exp Med Biol 2007;621:32-49.
23.
Bilimoria PM, Bonni A: Molecular control of axon branching. Neuroscientist 2013;19:16-24.
24.
Feng G, Laskowski MB, Feldheim DA, Wang H, Lewis R, Frisen J, et al: Roles for ephrins in positionally selective synaptogenesis between motor neurons and muscle fibers. Neuron 2000;25:295-306.
25.
Donoghue MJ, Merlie JP, Sanes JR: The Eph kinase ligand AL-1 is expressed by rostral muscles and inhibits outgrowth from caudal neurons. Mol Cell Neurosci 1996;8:185-198.
26.
Munoz LM, Zayachkivsky A, Kunz RB, Hunt JM, Wang G, Scott SA: Ephrin-A5 inhibits growth of embryonic sensory neurons. Dev Biol 2005;283:397-408.
27.
Moss A, Alvares D, Meredith-Middleton J, Robinson M, Slater R, Hunt SP, et al: Ephrin-A4 inhibits sensory neurite outgrowth and is regulated by neonatal skin wounding. Eur J Neurosci 2005;22:2413-2421.
28.
North HA, Karim A, Jacquin MF, Donoghue MJ: EphA4 is necessary for spatially selective peripheral somatosensory topography. Dev Dyn 2010;239:630-638.
29.
Matsunaga T, Greene MI, Davis JG: Distinct expression patterns of Eph receptors and ephrins relate to the structural organization of the adult rat peripheral vestibular system. Eur J Neurosci 2000;12:1599-1616.
30.
Webber A, Raz Y: Axon guidance cues in auditory development. Anat Rec A Discov Mol Cell Evol Biol 2006;288:390-396.
31.
Kitsukawa T, Shimizu M, Sanbo M, Hirata T, Taniguchi M, Bekku Y, et al: Neuropilin-semaphorin III/D-mediated chemorepulsive signals play a crucial role in peripheral nerve projection in mice. Neuron 1997;19:995-1005.
32.
Cowan CA, Yokoyama N, Saxena A, Chumley MJ, Silvany RE, Baker LA, et al: Ephrin-B2 reverse signaling is required for axon pathfinding and cardiac valve formation but not early vascular development. Dev Biol 2004;271:263-271.
33.
Dravis C, Yokoyama N, Chumley MJ, Cowan CA, Silvany RE, Shay J, et al: Bidirectional signaling mediated by ephrin-B2 and EphB2 controls urorectal development. Dev Biol 2004;271:272-290.
34.
Knoll B, Weinl C, Nordheim A, Bonhoeffer F: Stripe assay to examine axonal guidance and cell migration. Nat Protoc 2007;2:1216-1224.
35.
Yamout A, Spec A, Cosmano J, Kashyap M, Rochlin MW: Neurotrophic factor receptor expression and in vitro nerve growth of geniculate ganglion neurons that supply divergent nerves. Dev Neurosci 2005;27:288-298.
36.
Williams SE, Mann F, Erskine L, Sakurai T, Wei S, Rossi DJ, et al: Ephrin-B2 and EphB1 mediate retinal axon divergence at the optic chiasm. Neuron 2003;39:919-935.
37.
Henkemeyer M, Orioli D, Henderson JT, Saxton TM, Roder J, Pawson T, et al: Nuk controls pathfinding of commissural axons in the mammalian central nervous system. Cell 1996;86:35-46.
38.
Lopez GF, Krimm RF: Refinement of innervation accuracy following initial targeting of peripheral gustatory fibers. J Neurobiol 2006;66:1033-1043.
39.
Jevince AR, Kadison SR, Pittman AJ, Chien CB, Kaprielian Z: Distribution of EphB receptors and ephrin-B1 in the developing vertebrate spinal cord. J Comp Neurol 2006;497:734-750.
40.
Imondi R, Wideman C, Kaprielian Z: Complementary expression of transmembrane ephrins and their receptors in the mouse spinal cord: a possible role in constraining the orientation of longitudinally projecting axons. Development 2000;127:1397-1410.
41.
Ogawa Y, Takebayashi H, Takahashi M, Osumi N, Iwasaki Y, Ikenaka K: Gliogenic radial glial cells show heterogeneity in the developing mouse spinal cord. Dev Neurosci 2005;27:364-377.
42.
Krimm RF: Factors that regulate embryonic gustatory development. BMC Neurosci 2007;8(suppl 3):S4.
43.
Zhang C, Brandemihl A, Lau D, Lawton A, Oakley B: BDNF is required for the normal development of taste neurons in vivo. Neuroreport 1997;8:1013-1017.
44.
Ma L, Lopez GF, Krimm RF: Epithelial-derived brain-derived neurotrophic factor is required for gustatory neuron targeting during a critical developmental period. J Neurosci 2009;29:3354-3364.
45.
Fei D, Krimm RF: Taste neurons consist of both a large TrkB-receptor-dependent and a small TrkB-receptor-independent subpopulation. PLoS One 2013;8:e83460.
46.
Fritzsch B, Sarai PA, Barbacid M, Silos-Santiago I: Mice with a targeted disruption of the neurotrophin receptor trk B lose their gustatory ganglion cells early but do develop taste buds. Int J Dev Neurosci 1997;15:563-576.
47.
Hansen MJ, Dallal GE, Flanagan JG: Retinal axon response to ephrin-as shows a graded, concentration-dependent transition from growth promotion to inhibition. Neuron 2004;42:717-730.
48.
Kao TJ, Kania A: Ephrin-mediated cis-attenuation of Eph receptor signaling is essential for spinal motor axon guidance. Neuron 2011;71:76-91.
49.
Mann F, Ray S, Harris W, Holt C: Topographic mapping in dorsoventral axis of the Xenopus retinotectal system depends on signaling through ephrin-B ligands. Neuron 2002;35:461-473.
50.
McLaughlin T, O'Leary DD: Molecular gradients and development of retinotopic maps. Annu Rev Neurosci 2005;28:327-355.
51.
Rochlin MW, O'Connor R, Giger RJ, Verhaagen J, Farbman AI: Comparison of neurotrophin and repellent sensitivities of early embryonic geniculate and trigeminal axons. J Comp Neurol 2000;422:579-593.
52.
Jitpukdeebodintra S, Chai Y, Snead ML: Developmental patterning of the circumvallate papilla. Int J Dev Biol 2002;46:755-763.
53.
Zhou CQ, Lee J, Henkemeyer MJ, Lee KH: Disruption of ephrin B/Eph B interaction results in abnormal cochlear innervation patterns. Laryngoscope 2011;121:1541-1547.
54.
Defourny J, Poirrier AL, Lallemend F, Mateo SS, Neef J, Vanderhaeghen P, et al: Ephrin-A5/EphA4 signalling controls specific afferent targeting to cochlear hair cells. Nat Commun 2013;4:1438.
55.
Raft S, Andrade LR, Shao D, Akiyama H, Henkemeyer M, Wu DK: Ephrin-B2 governs morphogenesis of endolymphatic sac and duct epithelia in the mouse inner ear. Dev Biol 2014;390:51-67.
56.
Lin S, Wang B, Getsios S: Eph/ephrin signaling in epidermal differentiation and disease. Semin Cell Dev Biol 2012;23:92-101.
57.
Suksaweang S, Jiang TX, Roybal P, Chuong CM, Widelitz R: Roles of EphB3/ephrin-B1 in feather morphogenesis. Int J Dev Biol 2012;56:719-728.
58.
Patel AV, Huang T, Krimm RF: Lingual and palatal gustatory afferents each depend on both BDNF and NT-4, but the dependence is greater for lingual than palatal afferents. J Comp Neurol 2010;518:3290-3301.
59.
Dodd J, Morton SB, Karagogeos D, Yamamoto M, Jessell TM: Spatial regulation of axonal glycoprotein expression on subsets of embryonic spinal neurons. Neuron 1988;1:105-116.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.